Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. MA554828

Invitrogen™ Alnuctamab Humanized Recombinant Human Monoclonal Antibody

Catalog No. MA554828
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MA554828 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MA554828 Supplier Invitrogen™ Supplier No. MA554828
Add to Cart
Edge
Add to Cart

Description

Human Recombinant Monoclonal Antibody

Compatible with Direct ELISA.

Alnuctamab is a bispecific antibody that targets both BCMA (B-cell maturation antigen) and CD3, facilitating T-cell mediated cytotoxicity against BCMA-expressing multiple myeloma cells.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Alnuctamab Humanized
Applications ELISA
Classification Recombinant Monoclonal
Concentration 3.05 mg/mL
Conjugate Unconjugated
Formulation PBS with no preservative; pH 7.4
Gene Alias ALNUC; BMS-986349; CC-93269
Host Species Human
Immunogen Recombinant Human CD269/TNFRSF17/BCMA and CD3E.
Purification Method Protein A/G
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 κ, IgG1 λ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.